Skip to content
PIL Logo

Bavencio 20 mg/mL concentrate for solution for infusion

Last Updated on eMC 26-Sep-2017 View changes  | Merck - Pfizer Contact details

Black Triangle icon This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Certain risk materials on this website are intended for use by healthcare professionals only.

By proceeding you are confirming that you are a healthcare professional.

Want to avoid this message? If you are a Healthcare professional, REGISTER or LOGIN and you will not have to self-certify when you access Risk Minimisation Materials.

You can leave feedback on specific Risk Minimisation Materials or make general observations about how they are displayed on the eMC by leaving comments in the box below.

Please note that we are unable to respond to medical queries.

Bavencio 20 mg/mL concentrate for solution for infusion


Please enter your email address below

Tick here if you wish to recieve a response to your feedback

Risk Materials
VIEW

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

CLOSE THIS PANEL

Company contact details

Merck - Pfizer

Company image
Address

Bedfont Cross, Stanwell Road, Feltham, Middlesex, TW14 8NX, UK

Fax

+44 (0)208 818 7267

Medical Information e-mail
Telephone

+44 (0)208 818 7200

Medical Information Direct Line

+44 (0)208 818 7373

Medical Information Fax

+44 (0)208 818 7274

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

avelumab

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue